Non-Small Lung Carcinoma Market Revenue 2025 to 2034
Non-Small Lung Carcinoma Market Revenue 2025 to 2034
The non-small lung carcinoma market size is expected to grow from USD 10.01 billion in 2025 to USD 23.67 billion by 2034, with a CAGR of 10.03% throughout the forecast period from 2025 to 2034.
Report ID: 10114
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 9.1 Bn
Forecast Year,
USD USD 23.67 Bn
CAGR, 2025 -
10.03%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Non-Small Lung Carcinoma Market Size Analysis
Non-Small Lung Carcinoma Market Size By Type 2024 to 2034 (USD )
| Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Squamous Cell Carcinoma | 2.73 | 2.98 | 3.26 | 3.56 | 3.89 | 4.26 | 4.65 | 5.08 | 5.55 | 6.07 | 6.63 |
| Large Cell Carcinoma | 1.37 | 1.49 | 1.63 | 1.78 | 1.95 | 2.13 | 2.33 | 2.54 | 2.78 | 3.03 | 3.31 |
| Adenocarcinoma | 4.10 | 4.54 | 5.02 | 5.56 | 6.16 | 6.82 | 7.56 | 8.37 | 9.27 | 10.26 | 11.36 |
| Others | 0.91 | 1.00 | 1.10 | 1.21 | 1.33 | 1.47 | 1.61 | 1.78 | 1.95 | 2.15 | 2.37 |
Non-Small Lung Carcinoma Market Size By Treatment Type 2024 to 2034 (USD )
| Treatment Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemotherapy | 3.19 | 3.45 | 3.75 | 4.06 | 4.40 | 4.77 | 5.17 | 5.60 | 6.06 | 6.56 | 7.10 |
| Targeted Therapy | 3.64 | 4.05 | 4.49 | 4.99 | 5.55 | 6.16 | 6.85 | 7.60 | 8.45 | 9.38 | 10.41 |
| Immunotherapy | 2.28 | 2.51 | 2.78 | 3.07 | 3.39 | 3.74 | 4.13 | 4.57 | 5.04 | 5.57 | 6.15 |
Non-Small Lung Carcinoma Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 5.01 | 5.49 | 6.02 | 6.59 | 7.23 | 7.92 | 8.69 | 9.52 | 10.44 | 11.44 | 12.54 |
| Drug Store and Retail Pharmacy | 3.19 | 3.51 | 3.88 | 4.28 | 4.72 | 5.21 | 5.75 | 6.34 | 7.00 | 7.72 | 8.52 |
| Online Pharmacy | 0.91 | 1.01 | 1.12 | 1.25 | 1.39 | 1.54 | 1.71 | 1.90 | 2.11 | 2.34 | 2.60 |
Non-Small Lung Carcinoma Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 3.46 | 3.78 | 4.14 | 4.53 | 4.96 | 5.43 | 5.94 | 6.50 | 7.12 | 7.79 | 8.52 |
| Europe | 2.28 | 2.50 | 2.75 | 3.03 | 3.33 | 3.67 | 4.04 | 4.44 | 4.89 | 5.38 | 5.92 |
| Asia-Pacific | 2.00 | 2.22 | 2.47 | 2.74 | 3.04 | 3.38 | 3.75 | 4.16 | 4.61 | 5.12 | 5.68 |
| Latin America | 0.73 | 0.80 | 0.88 | 0.97 | 1.07 | 1.17 | 1.29 | 1.42 | 1.56 | 1.72 | 1.89 |
| Middle East & Africa | 0.64 | 0.70 | 0.77 | 0.85 | 0.93 | 1.03 | 1.13 | 1.24 | 1.37 | 1.51 | 1.66 |
Non-Small Lung Carcinoma Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
